These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28378545)

  • 1. Opsonophagocytic Antibodies to Serotype Ia, Ib, and III Group B Streptococcus among Korean Infants and in Intravenous Immunoglobulin Products.
    Kim HW; Lee JH; Cho HK; Lee H; Seo HS; Lee S; Kim KH
    J Korean Med Sci; 2017 May; 32(5):737-743. PubMed ID: 28378545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of Opsonophagocytic Antibodies against Serotype Ia, Ib, II, III, and V Group B Streptococcus among Korean Population.
    Lee JH; Kim HW; Kim KH
    J Korean Med Sci; 2018 Apr; 33(16):e127. PubMed ID: 29651820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotype distribution and clinical correlation of Streptococcus agalactiae causing invasive disease in infants and children in Taiwan.
    Lo CW; Liu HC; Lee CC; Lin CL; Chen CL; Jeng MJ; Chiu CH
    J Microbiol Immunol Infect; 2019 Aug; 52(4):578-584. PubMed ID: 29100794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a multiplexed opsonophagocytic killing assay (MOPA) for group B Streptococcus.
    Choi MJ; Noh JY; Cheong HJ; Kim WJ; Lin SM; Zhi Y; Lim JH; Lim S; Seo HS; Song JY
    Hum Vaccin Immunother; 2018 Jan; 14(1):67-73. PubMed ID: 28933634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging serotype III sequence type 17 group B streptococcus invasive infection in infants: the clinical characteristics and impacts on outcomes.
    Kao Y; Tsai MH; Lai MY; Chu SM; Huang HR; Chiang MC; Fu RH; Lu JJ; Hsu JF
    BMC Infect Dis; 2019 Jun; 19(1):538. PubMed ID: 31216993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-stratified analysis of serotype-specific baseline immunity against group B streptococcus.
    Choi MJ; Noh JY; Jang AY; Cheong HJ; Kim WJ; Song DJ; Cho GJ; Oh MJ; Zhi Y; Seo HS; Song JY
    Hum Vaccin Immunother; 2020 Jun; 16(6):1338-1344. PubMed ID: 31687869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etiological serotype and genotype distributions and clinical characteristics of group B streptococcus-inducing invasive disease among infants in South China.
    Zhu Y; Wu J; Zheng X; Liu D; Xu L; Chen D; Qiu W; Huang Z; Zhong R; Chen L; He M; Ma S; Lin Y; Lin X; Chen C
    BMC Pediatr; 2020 Apr; 20(1):146. PubMed ID: 32241251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural acquired humoral immunity against serotype-specific group B Streptococcus rectovaginal colonization acquisition in pregnant women.
    Kwatra G; Adrian PV; Shiri T; Buchmann EJ; Cutland CL; Madhi SA
    Clin Microbiol Infect; 2015 Jun; 21(6):568.e13-21. PubMed ID: 25680313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of serotype V among infants with invasive group B streptococcal infections in South Korea.
    Yoon IA; Jo DS; Cho EY; Choi EH; Lee HJ; Lee H
    Int J Infect Dis; 2015 Sep; 38():136-40. PubMed ID: 26026823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Group B Streptococcus (GBS) Serum Serotype-Specific Anticapsular Immunoglobulin G Concentration and Risk Reduction for Invasive GBS Disease in South African Infants: An Observational Birth-Cohort, Matched Case-Control Study.
    Madhi SA; Izu A; Kwatra G; Jones S; Dangor Z; Wadula J; Moultrie A; Adam Y; Pu W; Henry O; Briner C; Cutland CL
    Clin Infect Dis; 2021 Sep; 73(5):e1170-e1180. PubMed ID: 33341870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-mediated complement C3b/iC3b binding to group B Streptococcus in paired mother and baby serum samples in a refugee population on the Thailand-Myanmar border.
    Herbert J; Thomas S; Brookes C; Turner C; Turner P; Nosten F; Le Doare K; Hudson M; Heath PT; Gorringe A; Taylor S
    Clin Vaccine Immunol; 2015 Mar; 22(3):319-26. PubMed ID: 25589553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial.
    Madhi SA; Cutland CL; Jose L; Koen A; Govender N; Wittke F; Olugbosi M; Meulen AS; Baker S; Dull PM; Narasimhan V; Slobod K
    Lancet Infect Dis; 2016 Aug; 16(8):923-34. PubMed ID: 27139805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing a serocorrelate of protection against invasive group B streptococcus disease in pregnant women: a feasibility study.
    Carreras-Abad C; Cochet M; Hall T; Ramkhelawon L; Khalil A; Peregrine E; Vinayakarao L; Sivarajan S; Hamid R; Planche T; Sheridan E; Winchester S; Plumb J; Djennad A; Andrews N; Le Doare K; Heath P
    Health Technol Assess; 2019 Dec; 23(67):1-40. PubMed ID: 31855555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial.
    Heyderman RS; Madhi SA; French N; Cutland C; Ngwira B; Kayambo D; Mboizi R; Koen A; Jose L; Olugbosi M; Wittke F; Slobod K; Dull PM
    Lancet Infect Dis; 2016 May; 16(5):546-555. PubMed ID: 26869376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-ficolin and capsular polysaccharide-specific IgG in cord serum contribute synergistically to opsonophagocytic killing of serotype III and V group B streptococci.
    Fujieda M; Aoyagi Y; Matsubara K; Takeuchi Y; Fujimaki W; Matsushita M; Bohnsack JF; Takahashi S
    Infect Immun; 2012 Jun; 80(6):2053-60. PubMed ID: 22451515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically diverse serotypes III and VI substitute major clonal disseminated serotypes Ib and V as prevalent serotypes of Streptococcus agalactiae from 2007 to 2012.
    Wang YH; Lu CC; Chiu CH; Wang MH; Yang TH; Chu C
    J Microbiol Immunol Infect; 2016 Oct; 49(5):672-678. PubMed ID: 26316010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype Characterization of Group B Streptococcus Isolated From Infants With Invasive Diseases in South Korea.
    Kang HM; Lee HJ; Lee H; Jo DS; Lee HS; Kim TS; Shin JH; Yun KW; Lee B; Choi EH
    Pediatr Infect Dis J; 2017 Oct; 36(10):e242-e247. PubMed ID: 28060047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM197-Conjugate Vaccine During Pregnancy.
    Madhi SA; Koen A; Cutland CL; Jose L; Govender N; Wittke F; Olugbosi M; Sobanjo-Ter Meulen A; Baker S; Dull PM; Narasimhan V; Slobod K
    Clin Infect Dis; 2017 Nov; 65(11):1897-1904. PubMed ID: 29029127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotype distribution and invasive potential of group B streptococcus isolates causing disease in infants and colonizing maternal-newborn dyads.
    Madzivhandila M; Adrian PV; Cutland CL; Kuwanda L; Schrag SJ; Madhi SA
    PLoS One; 2011 Mar; 6(3):e17861. PubMed ID: 21445302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characteristics of group B Streptococcus isolates from infants in southern mainland China.
    Li J; Ji W; Gao K; Zhou H; Zhang L; Mu X; Yuan C; Guan X; Deng Q; Zhang L; Zhong H; Gao X; Gao F; Long Y; Chang CY; McIver DJ; Liu H
    BMC Infect Dis; 2019 Sep; 19(1):812. PubMed ID: 31533652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.